(Q41451381)

30 September 2017

1 reference

title

Adjuvant therapy of pancreatic cancer using monoclonal antibodies and immune response modifiers (English)

1 reference

30 September 2017

3

Büchler MW

1 reference

30 September 2017

1

Friess H

1 reference

30 September 2017

Gassmann M

2

1 reference

30 September 2017

1 February 1997

1 reference

International Journal of Pancreatology

30 September 2017

1 reference

30 September 2017

21

1 reference

30 September 2017

43-52

1 reference

30 September 2017

1

1 reference

PubMed ID

9127173

describes a project that uses

30 September 2017

1 reference

Immunohistochemistry in pancreatic cancer with new monoclonal antibodies

1 reference

12 December 2020

IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells

1 reference

12 December 2020

Human macrophages armed with murine immunoglobulin G2a antibodies to tumors destroy human cancer cells

1 reference

12 December 2020

A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancer.

1 reference

12 December 2020

Phase II clinical trial of a murine monoclonal antibody cytotoxic for gastrointestinal adenocarcinoma

1 reference

12 December 2020

[Immunotherapy of advanced pancreatic carcinoma with the monoclonal antibody BW 494]

1 reference

12 December 2020

Immunotherapy with Monoclonal Antibody (Mab) in Pancreatic Adenocarcinoma

1 reference

12 December 2020

Immunoscintigraphy and radioimmunotherapy in patients with pancreatic carcinoma.

1 reference

12 December 2020

Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody

1 reference

12 December 2020

Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis

1 reference

12 December 2020

Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness

1 reference

12 December 2020

The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies

1 reference

12 December 2020

Phase II trial of interferon gamma and monoclonal antibody 17-1A in pancreatic cancer: biologic and clinical effects

1 reference

12 December 2020

High-dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas. A preliminary report of a multi-institutional trial (Radiation Therapy Oncology Group Protocol 8801)

1 reference

12 December 2020

High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas

1 reference

12 December 2020

A monoclonal antibody with binding and inhibiting activity towards human pancreatic carcinoma cells. I. Immunohistological and immunochemical characterization of a murine monoclonal antibody selecting for well differentiated adenocarcinomas of the p

1 reference

12 December 2020

[Therapy of pancreatic carcinoma with the monoclonal antibody BW 494/32: first clinical results]

1 reference

12 December 2020

A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma

1 reference

12 December 2020

p53 mutations are common in pancreatic cancer and are absent in chronic pancreatitis

1 reference

12 December 2020

Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expression.

1 reference

12 December 2020

1 reference

12 December 2020

Treatment of duct carcinoma of the pancreas with the LH-RH analogue buserelin

1 reference

12 December 2020

Studies of pancreatic cancer utilizing monoclonal antibodies

1 reference

12 December 2020

Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival

1 reference

12 December 2020

Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma

1 reference

12 December 2020

Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer

1 reference

12 December 2020

Radiation therapy and 5-fluorouracil modulated by leucovorin for adenocarcinoma of the pancreas

1 reference

12 December 2020

Cancer statistics, 1989.

1 reference

12 December 2020

Randomised trial of epirubicin alone versus 5-fluorouracil, epirubicin and mitomycin C in locally advanced and metastatic carcinoma of the pancreas

1 reference

12 December 2020

Monoclonal antibody CO17-1A and leukapheresis in immunotherapy of pancreatic cancer.

1 reference

12 December 2020

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group

1 reference

12 December 2020

Overexpression of HER2/neu oncogene in human pancreatic carcinoma

1 reference

12 December 2020

Treatment of advanced pancreatic cancer with high-dose octreotide

1 reference

12 December 2020

Low-dose octreotide treatment is not effective in patients with advanced pancreatic cancer

1 reference

12 December 2020

Immunotherapy of pancreatic cancer with monoclonal antibody BW 494.

1 reference

12 December 2020

1 reference

12 December 2020

Anti-idiotypic antibodies to monoclonal antibody CO17-1A

1 reference

12 December 2020

Percolation and binding of monoclonal antibody BW494 to pancreatic carcinoma tissues during high dose immunotherapy and consequences for future therapy modalities

1 reference

12 December 2020

Trial of therapy with monoclonal antibody 17-1A in pancreatic carcinoma: preliminary results

1 reference

12 December 2020

Phase I trial of chimeric (human-mouse) monoclonal antibody L6 in patients with non-small-cell lung, colon, and breast cancer

1 reference

12 December 2020

Cancer of the pancreas. 50 years of surgery

1 reference

12 December 2020

Radioimmunotherapy of xenografts of human pancreatic carcinomas--intravenous and intratumoral application of 131I-labelled monoclonal antibodies.

1 reference

12 December 2020

Anti-idiotypic antibodies bear the internal image of a human tumor antigen

1 reference

12 December 2020

Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.

1 reference

12 December 2020

Colorectal carcinoma antigens detected by hybridoma antibodies

1 reference

12 December 2020

[TNM classification of malignant tumors: the new 1987 edition]

1 reference

12 December 2020

Anti-idiotype immunization of cancer patients: modulation of the immune response

1 reference

12 December 2020

Monoclonal antibody-beta-lactamase conjugates for the activation of a cephalosporin mustard prodrug

1 reference

12 December 2020

Radiotherapy for unresectable endocrine pancreatic carcinomas

1 reference

12 December 2020

Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage

1 reference

12 December 2020

Idiotypic cascades in cancer patients treated with monoclonal antibody CO17-1A

1 reference

12 December 2020

Surgical palliation for pancreatic cancer: developments during the past two decades

1 reference

12 December 2020

Activation of Prodrugs by Antibody-Enzyme Conjugates

1 reference

12 December 2020

GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma

1 reference

12 December 2020

Activation of prodrugs by antibody-enzyme conjugates: a new approach to cancer therapy.

1 reference

12 December 2020

Amphiregulin is a potent mitogen in human pancreatic-cancer cells - correlation with patient survival

1 reference

12 December 2020

Immunological tailoring of monoclonal antibodies for immunotherapy of pancreatic carcinoma

1 reference

12 December 2020

Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha

1 reference

12 December 2020

Effects of monoclonal antibody immunotherapy on patients with gastrointestinal adenocarcinoma

1 reference

12 December 2020

Possible role of anti-idiotypic antibodies in the induction of tumor immunity

1 reference

12 December 2020

Phase II multicenter evaluation of prolonged murine monoclonal antibody 17-1A therapy in pancreatic carcinoma

1 reference

12 December 2020

Identifiers

0 references

1 reference

PubMed ID

9127173